Monvadi B. Srichai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Monvadi B. Srichai has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Jill E. Jacobs
Panel Chair, New York University Medical Center, New York, New York
6 shared publications - James S. Babb
Department of Radiology, New York University Langone Medical Center, New York, NY, USA
4 shared publications - Leon Axel
New York University Langone Medical Center
4 shared publications Ruth P. Lim
4 shared publications- Danny Kim
Department of Radiology, NYU Langone Medical Center, 660 First Ave, New York, NY 10016
3 shared publications Elizabeth M. Hecht
3 shared publications
Latest Publications
- 28 January 2025
- Published by Wiley in Echocardiography
- Vol. 42 (2) , e70081
Effects of Isoproterenol Administration in Dobutamine Stress Echocardiography
Objective: This study evaluated the safety and efficacy of isoproterenol administration as an adjunct for achievement of target heart rate (HR) during dobutamine stress echocardiography (DSE). Background: In DSE, optimal accuracy is achieved when a target HR of 85% of maximal predicted heart rate (MPHR) is attained. Although rarely studied, intravenous isoproterenol has been used as an adjunct therapy to dobutamine and atropine to increase chronotropic response during pharmacologic stress testing. Methods: We identified 5569 DSE studies during which 264 received isoproterenol at MedStar Georgetown University Hospital from August 2011 to March 2023. Of the studies receiving isoproterenol, we collected clinical and echocardiographic parameters from each study to assess the effects of isoproterenol administration, including downstream events. Results: In 264 examinations with isoproterenol, 169 (64%) achieved 85% MPHR. Among these, 103 (39%) developed premature ventricular contractions, 79 (30%) developed symptoms including nausea/vomiting in 44 (17%), and chest pain in 15 (6%). There was a hypertensive response to stress in 53 studies (20%) and a hypotensive response in 37 studies (14%). There was no significant increase in 30‐day and 1‐year death when compared to studies that did not receive isoproterenol. Conclusions: Isoproterenol can effectively be used as an adjunctive agent in DSE to achieve the requisite hemodynamic stress for evaluation of ischemia, with a similar rate of side effects and complications compared to dobutamine and atropine stress testing.
- 28 January 2025
- Published by Wiley in Echocardiography
- Vol. 42 (2) , e70081
Effects of Isoproterenol Administration in Dobutamine Stress Echocardiography
Objective: This study evaluated the safety and efficacy of isoproterenol administration as an adjunct for achievement of target heart rate (HR) during dobutamine stress echocardiography (DSE). Background: In DSE, optimal accuracy is achieved when a target HR of 85% of maximal predicted heart rate (MPHR) is attained. Although rarely studied, intravenous isoproterenol has been used as an adjunct therapy to dobutamine and atropine to increase chronotropic response during pharmacologic stress testing. Methods: We identified 5569 DSE studies during which 264 received isoproterenol at MedStar Georgetown University Hospital from August 2011 to March 2023. Of the studies receiving isoproterenol, we collected clinical and echocardiographic parameters from each study to assess the effects of isoproterenol administration, including downstream events. Results: In 264 examinations with isoproterenol, 169 (64%) achieved 85% MPHR. Among these, 103 (39%) developed premature ventricular contractions, 79 (30%) developed symptoms including nausea/vomiting in 44 (17%), and chest pain in 15 (6%). There was a hypertensive response to stress in 53 studies (20%) and a hypotensive response in 37 studies (14%). There was no significant increase in 30‐day and 1‐year death when compared to studies that did not receive isoproterenol. Conclusions: Isoproterenol can effectively be used as an adjunctive agent in DSE to achieve the requisite hemodynamic stress for evaluation of ischemia, with a similar rate of side effects and complications compared to dobutamine and atropine stress testing.
- 11 December 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (1) , 139-148
How cardiac computed tomography angiography and positron emission tomography play complementary roles in a Practice's business model
- 11 December 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (1) , 139-148
How cardiac computed tomography angiography and positron emission tomography play complementary roles in a Practice's business model
- Open Access
- 22 November 2024
- Published by Wiley
Effects of Isoproterenol Administration in Dobutamine Stress Echocardiography
Not-yet-known not-yet-known not-yet-known unknown Objective: This study evaluated the safety and efficacy of isoproterenol administration as an adjunct for achievement of target heart rate during dobutamine stress echocardiography (DSE). Background: In DSE, optimal accuracy is achieved when a target heart rate of 85% of maximal predicted heart rate (MPHR) is attained. Although rarely studied, intravenous isoproterenol has been used as adjunct therapy to dobutamine and atropine to increase chronotropic response during pharmacologic stress testing. Methods: We identified 5569 DSE studies during which 264 received isoproterenol at MedStar Georgetown University Hospital from August 2011- March 2023. Of the studies receiving isoproterenol, we collected clinical and echocardiographic parameters from each study to assess the effects of isoproterenol administration, including downstream events. Results: In 264 examinations with isoproterenol, 169 (64%) achieved 85% MPHR, 103 (39%) developed premature ventricular contractions, 79 (30%) developed symptoms including nausea/vomiting in 44 (17%), and chest pain in 15 (6%). There was hypertensive response to stress in 53 studies (20%) and hypotensive response in 37 studies (14%). There was no significant increase in 30 day and 1 year death when compared to studies that did not receive isoproterenol. Conclusions: Isoproterenol can effectively be used as an adjunctive agent in DSE to achieve the requisite hemodynamic stress for evaluation of ischemia, with a similar rate of side effects and complications when compared to dobutamine and atropine stress testing.
- 22 November 2024
- Published by Wiley
Open AccessEffects of Isoproterenol Administration in Dobutamine Stress Echocardiography
Not-yet-known not-yet-known not-yet-known unknown Objective: This study evaluated the safety and efficacy of isoproterenol administration as an adjunct for achievement of target heart rate during dobutamine stress echocardiography (DSE). Background: In DSE, optimal accuracy is achieved when a target heart rate of 85% of maximal predicted heart rate (MPHR) is attained. Although rarely studied, intravenous isoproterenol has been used as adjunct therapy to dobutamine and atropine to increase chronotropic response during pharmacologic stress testing. Methods: We identified 5569 DSE studies during which 264 received isoproterenol at MedStar Georgetown University Hospital from August 2011- March 2023. Of the studies receiving isoproterenol, we collected clinical and echocardiographic parameters from each study to assess the effects of isoproterenol administration, including downstream events. Results: In 264 examinations with isoproterenol, 169 (64%) achieved 85% MPHR, 103 (39%) developed premature ventricular contractions, 79 (30%) developed symptoms including nausea/vomiting in 44 (17%), and chest pain in 15 (6%). There was hypertensive response to stress in 53 studies (20%) and hypotensive response in 37 studies (14%). There was no significant increase in 30 day and 1 year death when compared to studies that did not receive isoproterenol. Conclusions: Isoproterenol can effectively be used as an adjunctive agent in DSE to achieve the requisite hemodynamic stress for evaluation of ischemia, with a similar rate of side effects and complications when compared to dobutamine and atropine stress testing.
- 28 August 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (1) , 132-138
Cardiac CT angiography: Financial implications of different practice types
- 28 August 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (1) , 132-138
Cardiac CT angiography: Financial implications of different practice types
- 5 September 2019
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 21 (10) , 55
Multimodality Imaging in the Evaluation of Intracardiac Masses
Intracardiac masses are classified as neoplastic or non-neoplastic. Prognosis varies based on the diagnosis of the mass since treatment options differ greatly. As novel imaging techniques emerge, a multimodality approach to the evaluation of intracardiac masses becomes an important part of non-invasive evaluation prior to potential surgical planning or oncological treatment. The purpose of this article is to compare the available imaging modalities—echocardiography, cardiovascular magnetic resonance, cardiac computed tomography, nuclear imaging, and emerging novel hybrid imaging techniques for future clinical applications—and to review the characteristic features seen on those modalities for the most common intracardiac masses.
- 5 September 2019
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 21 (10) , 55
Multimodality Imaging in the Evaluation of Intracardiac Masses
Intracardiac masses are classified as neoplastic or non-neoplastic. Prognosis varies based on the diagnosis of the mass since treatment options differ greatly. As novel imaging techniques emerge, a multimodality approach to the evaluation of intracardiac masses becomes an important part of non-invasive evaluation prior to potential surgical planning or oncological treatment. The purpose of this article is to compare the available imaging modalities—echocardiography, cardiovascular magnetic resonance, cardiac computed tomography, nuclear imaging, and emerging novel hybrid imaging techniques for future clinical applications—and to review the characteristic features seen on those modalities for the most common intracardiac masses.
- 1 October 2016
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 4 (S1) , S46
Severe ischemic cardiomyopathy—a new answer in management?
Severe ischemic cardiomyopathy—a new answer in management?
- 1 October 2016
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 4 (S1) , S46
Severe ischemic cardiomyopathy—a new answer in management?
Severe ischemic cardiomyopathy—a new answer in management?
- 1 January 2016
- Published by Elsevier in The American Journal of Cardiology
- Vol. 117 (1) , 135-140
Diagnostic Performance of Cardiac Magnetic Resonance Imaging and Echocardiography in Evaluation of Cardiac and Paracardiac Masses
- 1 January 2016
- Published by Elsevier in The American Journal of Cardiology
- Vol. 117 (1) , 135-140
Diagnostic Performance of Cardiac Magnetic Resonance Imaging and Echocardiography in Evaluation of Cardiac and Paracardiac Masses
- 1 February 2015
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 17 (3) , 1-12
Role of Non-invasive Imaging in the Work-Up of Cardiomyopathies
Cardiomyopathy is an intrinsic structural disorder of the myocardium that may result in ventricular dysfunction and can progress to clinical heart failure. Non-invasive imaging modalities can determine whether abnormalities are present in the myocardium, valves, pericardium, or vessels. These imaging techniques can also present important prognostic information, as well as direct treatment and further management. Echocardiography is the most common imaging technique used for the initial diagnosis and management of cardiomyopathy; however, other imaging modalities, including nuclear cardiac imaging, cardiac magnetic resonance imaging, and cardiac computed tomography, may play an important role depending on the underlying etiology of the cardiomyopathy. This article reviews the role of non-invasive imaging in the work-up and management of patients with cardiomyopathy.
- 1 February 2015
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 17 (3) , 1-12
Role of Non-invasive Imaging in the Work-Up of Cardiomyopathies
Cardiomyopathy is an intrinsic structural disorder of the myocardium that may result in ventricular dysfunction and can progress to clinical heart failure. Non-invasive imaging modalities can determine whether abnormalities are present in the myocardium, valves, pericardium, or vessels. These imaging techniques can also present important prognostic information, as well as direct treatment and further management. Echocardiography is the most common imaging technique used for the initial diagnosis and management of cardiomyopathy; however, other imaging modalities, including nuclear cardiac imaging, cardiac magnetic resonance imaging, and cardiac computed tomography, may play an important role depending on the underlying etiology of the cardiomyopathy. This article reviews the role of non-invasive imaging in the work-up and management of patients with cardiomyopathy.
- 23 May 2014
- Published by Springer Nature in Current Cardiovascular Imaging Reports
- Vol. 7 (7) , 1-10
Coronary CT Angiography in Patients with Atrial Fibrillation
- 23 May 2014
- Published by Springer Nature in Current Cardiovascular Imaging Reports
- Vol. 7 (7) , 1-10
Coronary CT Angiography in Patients with Atrial Fibrillation
- 1 January 2014
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 8 (1) , 85-87
Right coronary artery aneurysm with aneurysmal dilation and thrombosis of the sinoatrial nodal branch mimicking a right atrial mass
- 1 January 2014
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 8 (1) , 85-87
Right coronary artery aneurysm with aneurysmal dilation and thrombosis of the sinoatrial nodal branch mimicking a right atrial mass